Sugammadex, sold under the brand name Bridion, is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium [5] in general anaesthesia. It is the first selective relaxant binding agent (SRBA).

Apr 17, 2024 · Sugammadex: side effects, dosage, interactions, FAQs, reviews. Used for: reversal of neuromuscular blockade, reversal of nondepolarizing muscle relaxants

Feb 1, 2021 · Sugammadex is a modified gamma-cyclodextrin that is used to reverse steroidal non-depolarizing neuromuscular blocking drugs rocuronium and vecuronium. Residual neuromuscular blockade is common after surgery, with an …

Sugammadex is the first clinical representative of a new class of drugs called selective relaxant binding agents. It has revolutionized the way anesthesiologists think about drug reversal. Sugammadex selectively binds rocuronium or vecuronium, thereby reversing their neuromuscular blocking action.

Sugammadex (ORG 25969) is a unique neuromuscular reversal drug; a novel cyclodextrin, the first in a new class of selective relaxant binding agents, which reverse neuromuscular blockade (NMB) with the aminosteroid non-depolarizing muscle relaxants ...

BRIDION (sugammadex) injection is a sterile, clear, colorless to slightly yellow-brown, nonpyrogenic - aqueous solution intended for intravenous infusion. BRIDION is available as follows: • 200...

Feb 1, 2025 · Sugammadex injection is used to reverse the effects of the muscle relaxants rocuronium and vecuronium, which are given to patients during surgery. This medicine is to be given by or under the supervision of your doctor. This product is …

Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery.

Selective relaxant binding agent for reversal of neuromuscular blockade (NMB) induced by rocuronium or vecuronium in adults undergoing surgery. Doses and timing of administration...

May 10, 2024 · Selective relaxant binding agent; modified γ-cyclodextrin. Used to reverse neuromuscular blockade induced by rocuronium or vecuronium in patients undergoing surgery.